178 related articles for article (PubMed ID: 37067914)
1. Patient-Derived iPSCs Faithfully Represent the Genetic Diversity and Cellular Architecture of Human Acute Myeloid Leukemia.
Kotini AG; Carcamo S; Cruz-Rodriguez N; Olszewska M; Wang T; Demircioglu D; Chang CJ; Bernard E; Chao MP; Majeti R; Luo H; Kharas MG; Hasson D; Papapetrou EP
Blood Cancer Discov; 2023 Jul; 4(4):318-335. PubMed ID: 37067914
[TBL] [Abstract][Full Text] [Related]
2. Reprogramming of Acute Myeloid Leukemia Patients Cells: Harboring Cancer Mutations Requires Targeting of AML Hierarchy.
Golubeva D; Porras DP; Doyle M; Reid JC; Tanasijevic B; Boyd AL; Vojnits K; Elrafie A; Qiao A; Bhatia M
Stem Cells Transl Med; 2023 Jun; 12(6):334-354. PubMed ID: 37226319
[TBL] [Abstract][Full Text] [Related]
3. iPSC Models of Leukemia Come of Age.
Doulatov S
Blood Cancer Discov; 2023 Jul; 4(4):252-253. PubMed ID: 37067903
[TBL] [Abstract][Full Text] [Related]
4. Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of Disease.
Chao MP; Gentles AJ; Chatterjee S; Lan F; Reinisch A; Corces MR; Xavy S; Shen J; Haag D; Chanda S; Sinha R; Morganti RM; Nishimura T; Ameen M; Wu H; Wernig M; Wu JC; Majeti R
Cell Stem Cell; 2017 Mar; 20(3):329-344.e7. PubMed ID: 28089908
[TBL] [Abstract][Full Text] [Related]
5. Cellular Reprogramming Allows Generation of Autologous Hematopoietic Progenitors From AML Patients That Are Devoid of Patient-Specific Genomic Aberrations.
Salci KR; Lee JH; Laronde S; Dingwall S; Kushwah R; Fiebig-Comyn A; Leber B; Foley R; Dal Cin A; Bhatia M
Stem Cells; 2015 Jun; 33(6):1839-49. PubMed ID: 25764124
[TBL] [Abstract][Full Text] [Related]
6. Stage-Specific Human Induced Pluripotent Stem Cells Map the Progression of Myeloid Transformation to Transplantable Leukemia.
Kotini AG; Chang CJ; Chow A; Yuan H; Ho TC; Wang T; Vora S; Solovyov A; Husser C; Olszewska M; Teruya-Feldstein J; Perumal D; Klimek VM; Spyridonidis A; Rampal RK; Silverman L; Reddy EP; Papaemmanuil E; Parekh S; Greenbaum BD; Leslie CS; Kharas MG; Papapetrou EP
Cell Stem Cell; 2017 Mar; 20(3):315-328.e7. PubMed ID: 28215825
[TBL] [Abstract][Full Text] [Related]
7. Modeling Leukemia Stem Cells with Patient-Derived Induced Pluripotent Stem Cells.
Deslauriers AG; Kotini AG; Papapetrou EP
Methods Mol Biol; 2021; 2185():411-422. PubMed ID: 33165864
[TBL] [Abstract][Full Text] [Related]
8. Studying leukemia stem cell properties and vulnerabilities with human iPSCs.
Spyrou N; Papapetrou EP
Stem Cell Res; 2020 Dec; 50():102117. PubMed ID: 33388708
[TBL] [Abstract][Full Text] [Related]
9. Acute Myeloid Leukemia iPSCs Reveal a Role for RUNX1 in the Maintenance of Human Leukemia Stem Cells.
Wesely J; Kotini AG; Izzo F; Luo H; Yuan H; Sun J; Georgomanoli M; Zviran A; Deslauriers AG; Dusaj N; Nimer SD; Leslie C; Landau DA; Kharas MG; Papapetrou EP
Cell Rep; 2020 Jun; 31(9):107688. PubMed ID: 32492433
[TBL] [Abstract][Full Text] [Related]
10. Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency.
Muñoz-López A; Romero-Moya D; Prieto C; Ramos-Mejía V; Agraz-Doblas A; Varela I; Buschbeck M; Palau A; Carvajal-Vergara X; Giorgetti A; Ford A; Lako M; Granada I; Ruiz-Xivillé N; Rodríguez-Perales S; Torres-Ruíz R; Stam RW; Fuster JL; Fraga MF; Nakanishi M; Cazzaniga G; Bardini M; Cobo I; Bayon GF; Fernandez AF; Bueno C; Menendez P
Stem Cell Reports; 2016 Oct; 7(4):602-618. PubMed ID: 27666791
[TBL] [Abstract][Full Text] [Related]
11. Modeling leukemia with pediatric acute leukemia patient-derived iPSCs.
Li T; Zhang Y; Li Y; Wang X; Bao W; Huang J; Ma Y; Li S; Wang S; Yang Y; Liu Y; Gao Y; Feng H; Li Y
Stem Cell Res; 2021 Jul; 54():102404. PubMed ID: 34111697
[TBL] [Abstract][Full Text] [Related]
12. Brief Report: Human Acute Myeloid Leukemia Reprogramming to Pluripotency Is a Rare Event and Selects for Patient Hematopoietic Cells Devoid of Leukemic Mutations.
Lee JH; Salci KR; Reid JC; Orlando L; Tanasijevic B; Shapovalova Z; Bhatia M
Stem Cells; 2017 Sep; 35(9):2095-2102. PubMed ID: 28758276
[TBL] [Abstract][Full Text] [Related]
13. An iPSC line derived from a human acute myeloid leukemia cell line (HL-60-iPSC) retains leukemic abnormalities and displays myeloid differentiation defects.
Yamasaki AE; Warshaw JN; Kyalwazi BL; Matsui H; Jepsen K; Panopoulos AD
Stem Cell Res; 2020 Dec; 49():102096. PubMed ID: 33370871
[TBL] [Abstract][Full Text] [Related]
14. Generation of a MLL-AF9-specific stem cell model of acute monocytic leukemia.
Chiew MY; Boo NY; Voon K; Cheong SK; Leong PP
Leuk Lymphoma; 2017 Jan; 58(1):162-170. PubMed ID: 27185517
[TBL] [Abstract][Full Text] [Related]
15. An induced pluripotent stem cell t(7;12)(q36;p13) acute myeloid leukemia model shows high expression of MNX1 and a block in differentiation of the erythroid and megakaryocytic lineages.
Nilsson T; Waraky A; Östlund A; Li S; Staffas A; Asp J; Fogelstrand L; Abrahamsson J; Palmqvist L
Int J Cancer; 2022 Sep; 151(5):770-782. PubMed ID: 35583991
[TBL] [Abstract][Full Text] [Related]
16. DNMT3A Haploinsufficiency Transforms FLT3ITD Myeloproliferative Disease into a Rapid, Spontaneous, and Fully Penetrant Acute Myeloid Leukemia.
Meyer SE; Qin T; Muench DE; Masuda K; Venkatasubramanian M; Orr E; Suarez L; Gore SD; Delwel R; Paietta E; Tallman MS; Fernandez H; Melnick A; Le Beau MM; Kogan S; Salomonis N; Figueroa ME; Grimes HL
Cancer Discov; 2016 May; 6(5):501-15. PubMed ID: 27016502
[TBL] [Abstract][Full Text] [Related]
17. Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients.
Sakurai M; Kunimoto H; Watanabe N; Fukuchi Y; Yuasa S; Yamazaki S; Nishimura T; Sadahira K; Fukuda K; Okano H; Nakauchi H; Morita Y; Matsumura I; Kudo K; Ito E; Ebihara Y; Tsuji K; Harada Y; Harada H; Okamoto S; Nakajima H
Leukemia; 2014 Dec; 28(12):2344-54. PubMed ID: 24732596
[TBL] [Abstract][Full Text] [Related]
18. Challenges in Cell Fate Acquisition to Scid-Repopulating Activity from Hemogenic Endothelium of hiPSCs Derived from AML Patients Using Forced Transcription Factor Expression.
Porras DP; Reid JC; Tanasijevic B; Golubeva D; Boyd AL; Bhatia M
Cells; 2022 Jun; 11(12):. PubMed ID: 35741044
[TBL] [Abstract][Full Text] [Related]
19. Sequential CRISPR gene editing in human iPSCs charts the clonal evolution of myeloid leukemia and identifies early disease targets.
Wang T; Pine AR; Kotini AG; Yuan H; Zamparo L; Starczynowski DT; Leslie C; Papapetrou EP
Cell Stem Cell; 2021 Jun; 28(6):1074-1089.e7. PubMed ID: 33571445
[TBL] [Abstract][Full Text] [Related]
20. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones.
Al-Mawali A; Gillis D; Lewis I
J Hematol Oncol; 2016 Jul; 9(1):61. PubMed ID: 27465508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
